$54.42
-0.21-0.38%
At close: -
$53.99
-0.43-0.79%
After Hours: 6:51 PM EDT
Comments
Loading...
Latest Sarepta Therapeutics Stock News | NASDAQ:SRPT | Benzinga
Get the latest news on Sarepta Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Sarepta Therapeutics performance
Categories: All
Tuesday, April 15, 2025
Friday, April 11, 2025
Monday, April 07, 2025
Friday, April 04, 2025
Thursday, April 03, 2025
- Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death
- Smart Money Is Betting Big In SRPT Options
- Sarepta Therapeutics shares are trading lower...
- Apple To $250? Here Are 10 Top Analyst Forecasts For Thursday
- Deep Dive Into Sarepta Therapeutics Stock: Analyst Perspectives (18 Ratings)
- Needham Maintains Buy on Sarepta Therapeutics...
Wednesday, April 02, 2025
Monday, March 31, 2025
Friday, March 21, 2025
Thursday, March 20, 2025
Wednesday, March 19, 2025
Tuesday, March 18, 2025
- 12 Analysts Have This To Say About Sarepta Therapeutics
- Wall Street Falters, Magnificent Seven Hit 7-Month Lows, Gold Rockets On Haven Demand: What's Driving Markets Tuesday?
- S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Needham Reiterates Buy on Sarepta Therapeutic...
- Sarepta Therapeutics Reports Patient Death Post Elevidys Gene Therapy Treatment, Stock Plunges
- Cantor Fitzgerald Reiterates Overweight on Sa...
- Sarepta Therapeutics shares are trading lower...
- Sarepta Therapeutics Reports A Patient Death ...
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session